D-0085-2022 Class II Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-0085-2022 was initiated by Dr. Reddy's Laboratories, Inc. on Oct 5, 2021 and is designated Class II. Reason for recall: Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10… The recall status is terminated (terminated Feb 16, 2023). Affected quantity: 696 bottles.

Recall details

Product Type
Drugs
Report Date
Nov 10, 2021
Initiation Date
Oct 5, 2021
Termination Date
Feb 16, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
696 bottles

Product description

Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/40 mg, 500 count bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106, USA, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA NDC 43598-743-05

Reason for recall

Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle

Distribution pattern

Nationwide in the US

Code information

L100208, exp 01/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0085-2022
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0085-2022. Report a data issue: hello@regdatalab.com.